![]() ![]() Implications for Nursing: Clinicians should assess and identify patients with diabetes or prediabetes undergoing treatment for cancer. This study confirmed that older age, as well as having higher BMI and having multiple comorbidities, were associated with increased mean glycemic levels. No differences in symptom severity or quality-of-life (QOL) scores were found among the three diabetic states.Ĭonclusions: This study is the first to evaluate for associations between diabetic states and symptom severity and QOL scores in patients receiving CTX. Patients in the diabetic and prediabetic states had a higher BMI compared to nondiabetic patients. Patients in the prediabetic state were older aged. Patients in the diabetic state reported a higher number of comorbid conditions and were more likely to be African American. ![]() ![]() Main Research Variables: HbA1c, symptom severity scores, patient and clinical characteristics (e.g., age, gender, comorbidities, sociodemographic information, body mass index, lifestyle factors).įindings: HbA1c results showed 9% of the sample in the diabetic and 26% in the prediabetic state. Descriptive statistics and one-way analyses of variance were used in the analyses. Glycosylated hemoglobin A1c (HbA1c) was evaluated to determine diabetic state. Methods: Patients completed demographic and symptom questionnaires. Sample: 244 outpatients with breast, gastrointestinal, gynecologic, and lung cancers. Setting: Two comprehensive cancer centers, one Veterans Affairs hospital, and four community-based oncology programs. Purpose/Objectives: To assess the effects of high blood sugar at the levels of diabetic or prediabetic states during cancer treatment because patients undergoing chemotherapy (CTX) experience multiple symptoms that vary among individuals and may be affected by glucose levels. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |